Acquired Expression of Periostin by Human Breast Cancers Promotes Tumor Angiogenesis through Up-Regulation of Vascular Endothelial Growth Factor Receptor 2 Expression

REFERENCES

• Abu-Ghazaleh, R., J. Kabir, H. Jia, M. Lobo, and I. Zachary. 2001. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem. J. 360:255–264.
   PubMed Web of Science ®Google Scholar
• Biroccio, A., Candiloro A., Mottolese M., Sapora O., Albini A., Zupi G., and Del Bufalo D.. 2000. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. FASEB J. 14:652–660.
   PubMedGoogle Scholar
• Dougher, M., and Terman B. I.. 1999. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization. Oncogene 18:1619–1627.
   PubMed Web of Science ®Google Scholar
• Folkman, J. 1996. Tumor angiogenesis and tissue factor. Nat. Med. 2:167–168.
   PubMed Web of Science ®Google Scholar
• Folkman, J., Watson K., Ingber D., and Hanahan D.. 1989. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58–61.
   PubMed Web of Science ®Google Scholar
• Gillan, L., Matei D., Fishman D. A., Gerbin C. S., Karlan B. Y., and Chang D. D.. 2002. Periostin secreted by epithelial ovarian carcinoma is a ligand for αVβ3 and αVβ5 integrins and promotes cell motility. Cancer Res. 62:5358–5364.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and Weinberg R. A.. 2000. The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Horiuchi, K., Amizuka N., Takeshita S., Takamatsu H., Katsuura M., Ozawa H., Toyama Y., Bonewald L. F., and Kudo A.. 1999. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 14:1239–1249.
   PubMed Web of Science ®Google Scholar
• Ismail, R. S., Baldwin R. L., Fang J., Browning D., Karlan B. Y., Gasson J. C., and Chang D. D.. 2000. Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res. 60:6744–6749.
   PubMed Web of Science ®Google Scholar
• Jendraschak, E., and Sage E. H.. 1996. Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology. Semin. Cancer Biol. 7:139–146.
   PubMed Web of Science ®Google Scholar
• Jiang, X. R., Jimenez G., Chang E., Frolkis M., Kusler B., Sage M., Beeche M., Bodnar A. G., Wahl G. M., Tlsty T. D., and Chiu C. P.. 1999. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21:111–114.
   PubMed Web of Science ®Google Scholar
• Kasahara, Y., Tuder R. M., Taraseviciene-Stewart L., Le Cras T. D., Abman S., Hirth P. K., Waltenberger J., and Voelkel N. F.. 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Investig. 106:1311–1319.
   PubMed Web of Science ®Google Scholar
• Kim, K. J., Li B., Winer J., Armanini M., Gillett N., Phillips H. S., and Ferrara N.. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841–844.
   PubMed Web of Science ®Google Scholar
• Lal, A., Lash A. E., Altschul S. F., Velculescu V., Zhang L., McLendon R. E., Marra M. A., Prange C., Morin P. J., Polyak K., Papadopoulos N., Vogelstein B., Kinzler K. W., Strausberg R. L., and Riggins G. J.. 1999. A public database for gene expression in human cancers. Cancer Res. 59:5403–5407.
   PubMed Web of Science ®Google Scholar
• Ledda, M. F., Adris S., Bravo A. I., Kairiyama C., Bover L., Chernajovsky Y., Mordoh J., and Podhajcer O. L.. 1997. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat. Med. 3:171–176.
   PubMed Web of Science ®Google Scholar
• Lin, P., Sankar S., Shan S., Dewhirst M. W., Polverini P. J., Quinn T. Q., and Peters K. G.. 1998. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ. 9:49–58.
   PubMedGoogle Scholar
• Lochter, A., Werb Z., and Bissell M. J.. 1999. Transcriptional regulation of stromelysin-1 gene expression is altered during progression of mouse mammary epithelial cells from functionally normal to malignant. Matrix Biol. 18:455–467.
   PubMedGoogle Scholar
• Lyden, D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N. R., Crystal R. G., Moore M. A., Hajjar K. A., Manova K., Benezra R., and Rafii S.. 2001. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7:1194–1201.
   PubMed Web of Science ®Google Scholar
• Millauer, B., Longhi M. P., Plate K. H., Shawver L. K., Risau W., Ullrich A., and Strawn L. M.. 1996. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56:1615–1620.
   PubMed Web of Science ®Google Scholar
• Morales, C. P., Holt S. E., Ouellette M., Kaur K. J., Yan Y., Wilson K. S., White M. A., Wright W. E., and Shay J. W.. 1999. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21:115–118.
   PubMed Web of Science ®Google Scholar
• Perou, C. M., Jeffrey S. S., van de Rijn M., Rees C. A., Eisen M. B., Ross D. T., Pergamenschikov A., Williams C. F., Zhu S. X., Lee J. C., Lashkari D., Shalon D., Brown P. O., and Botstein D.. 1999. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 96:9212–9217.
   PubMed Web of Science ®Google Scholar
• Perou, C. M., Sorlie T., Eisen M. B., van de Rijn M., Jeffrey S. S., Rees C. A., Pollack J. R., Ross D. T., Johnsen H., Akslen L. A., Fluge O., Pergamenschikov A., Williams C., Zhu S. X., Lonning P. E., Borresen-Dale A. L., Brown P. O., and Botstein D.. 2000. Molecular portraits of human breast tumours. Nature 406:747–752.
   PubMed Web of Science ®Google Scholar
• Putz, E., Witter K., Offner S., Stosiek P., Zippelius A., Johnson J., Zahn R., Riethmuller G., and Pantel K.. 1999. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res. 59:241–248.
   PubMed Web of Science ®Google Scholar
• Rich, J. N., Shi Q., Hjelmeland M., Cummings T. J., Kuan C. T., Bigner D. D., Counter C. M., and Wang X. F.. 2003. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J. Biol. Chem. 278:15951–15957.
   PubMed Web of Science ®Google Scholar
• Sasaki, H., Auclair D., Kaji M., Fukai I., Kiriyama M., Yamakawa Y., Fujii Y., and Chen L. B.. 2001. Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients. Cancer Lett. 172:37–42.
   PubMedGoogle Scholar
• Sasaki, H., Dai M., Auclair D., Fukai I., Kiriyama M., Yamakawa Y., Fujii Y., and Chen L. B.. 2001. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 92:843–848.
   PubMed Web of Science ®Google Scholar
• Sasaki, H., Yu C. Y., Dai M., Tam C., Loda M., Auclair D., Chen L. B., and Elias A.. 2003. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res. Treat. 77:245–252.
   PubMed Web of Science ®Google Scholar
• Stacker, S. A., Caesar C., Baldwin M. E., Thornton G. E., Williams R. A., Prevo R., Jackson D. G., Nishikawa S., Kubo H., and Achen M. G.. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7:186–191.
   PubMed Web of Science ®Google Scholar
• Takeshita, S., Kikuno R., Tezuka K., and Amann E.. 1993. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 294:271–278.
   PubMed Web of Science ®Google Scholar
• Tang, S., Gao Y., and Ware J. A.. 1999. Enhancement of endothelial cell migration and in vitro tube formation by TAP20, a novel beta 5 integrin-modulating, PKC theta-dependent protein. J. Cell Biol. 147:1073–1084.
   PubMedGoogle Scholar
• Vajkoczy, P., Menger M. D., Goldbrunner R., Ge S., Fong T. A., Vollmar B., Schilling L., Ullrich A., Hirth K. P., Tonn J. C., Schmiedek P., and Rempel S. A.. 2000. Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC. Int. J. Cancer 87:261–268.
   PubMed Web of Science ®Google Scholar
• van 't Veer, L. J., H. Dai, M. J. van de Vijver, Y. D. He, A. A. Hart, M. Mao, H. L. Peterse, K. van der Kooy, M. J. Marton, A. T. Witteveen, G. J. Schreiber, R. M. Kerkhoven, C. Roberts, P. S. Linsley, R. Bernards, and S. H. Friend. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536.
   PubMed Web of Science ®Google Scholar
• Velculescu, V. E., Vogelstein B., and Kinzler K. W.. 2000. Analysing uncharted transcriptomes with SAGE. Trends Genet. 16:423–425.
   PubMed Web of Science ®Google Scholar
• Velculescu, V. E., Zhang L., Vogelstein B., and Kinzler K. W.. 1995. Serial analysis of gene expression. Science 270:484–487.
   PubMed Web of Science ®Google Scholar
• West, M., Blanchette C., Dressman H., Huang E., Ishida S., Spang R., Zuzan H., Olson J. A., Jr., Marks J. R., and Nevins J. R.. 2001. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. USA 98:11462–11467.
   PubMed Web of Science ®Google Scholar
• Yancopoulos, G. D., Davis S., Gale N. W., Rudge J. S., Wiegand S. J., and Holash J.. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242–248.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Zhou W., Velculescu V. E., Kern S. E., Hruban R. H., Hamilton S. R., Vogelstein B., and Kinzler K. W.. 1997. Gene expression profiles in normal and cancer cells. Science 276:1268–1272.
   PubMed Web of Science ®Google Scholar